Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Author Correction: Integration of whole-body [¹⁸F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Sci Rep. 2024 Nov 28;14(1):29632. doi: 10.1038/s41598-024-78537-6.

Klev Diamanti^#¹, Robin Visvanathar^#², Maria J Pereira³, Marco Cavalli⁴, Gang Pan⁴, Chanchal Kumar^{5

6}, Stanko Skrtic^{7

8}, Ulf Risérus⁹, Jan W Eriksson³, Joel Kullberg^{2

10}, Jan Komorowski^{1

11}, Claes Wadelius⁴, Håkan Ahlström^{12

13}

¹ Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
² Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.
³ Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
⁴ Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁵ Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
⁶ Karolinska Institute/AstraZeneca Integrated CardioMetabolic Centre (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden.
⁷ Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden.
⁸ Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁹ Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
¹⁰ Antaros Medical AB, Mölndal, Sweden.
¹¹ Institute of Computer Science, PAN, Warsaw, Poland.
¹² Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden. hakan.ahlstrom@radiol.uu.se.
¹³ Antaros Medical AB, Mölndal, Sweden. hakan.ahlstrom@radiol.uu.se.

^# Contributed equally.

No abstract available